CVS Health’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCIT
CVS Health's VCIT Position: Q3 2026 in Review
CVS Health held its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) position steady in Q3 2026 at 60,000 shares worth $4.7M. The position accounts for 1.09% of the portfolio, ranked #21.
CVS Health first reported a position in VCIT in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.96M in Q1 2026. 1,340 funds tracked by Wall St. Rank hold VCIT as of Q3 2026.
- CVS Health held 60,000 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $4.7M as of Q3 2026.
- CVS Health left its Vanguard Intermediate-Term Corporate Bond ETF share count unchanged in Q3 2026.
- Vanguard Intermediate-Term Corporate Bond ETF made up 1.09% of CVS Health's portfolio in Q3 2026, its #21 holding.
- CVS Health first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q1 2026 and has held it in 3 quarters since.
- CVS Health's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $4.96M in Q1 2026.
- 1,340 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q3 2026.
Based on CVS Health's 13F filing for Q3 2026, filed 5 Nov 2026.